Sorrento Therapeutics (SRNE) Stock Chart & Stock Price History → Urgent: Protect Your Investments from a Chinese Invasion (From Behind the Markets) (Ad) Free SRNE Stock Alerts $0.0080 0.00 (0.00%) (As of 03/27/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsSocial MediaSustainabilityStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsSocial MediaSustainability Sorrento Therapeutics Stock Price Performance5 Day Performance+12.50%1 Month Performance-66.29%3 Month Performance-93.08%6 Month Performance-90.11%Year-To-Date Performance-92.71%1 Year Performance-97.23% Receive SRNE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sorrento Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsUrgent: Protect Your Investments from a Chinese InvasionAn alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.Click here to get my exclusive report NOW >>> SRNE Stock Chart for Thursday, March, 28, 2024 SRNE Chart by TradingView Sorrento Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/27/2024$0.01$0.01$0.01$0.01153,597 shs$4.25 million03/26/2024$0.01$0.01+12.50%$0.02$0.0161,686 shs$4.25 million03/25/2024$0.01$0.01$0.01$0.01103,819 shs$3.78 million03/22/2024$0.02$0.01-60.00%$0.01$0.01103,819 shs$3.78 million03/21/2024$0.01$0.02+100.00%$0.02$0.0167,781 shs$9.44 million03/20/2024$0.01$0.01-9.09%$0.02$0.01226,387 shs$4.72 million Get the Latest News and Ratings for SRNE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sorrento Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 03/19/2024$0.02$0.01-38.89%$0.02$0.01101,512 shs$5.19 million03/18/2024$0.02$0.02$0.02$0.0167,518 shs$8.49 million03/15/2024$0.01$0.02+38.46%$0.02$0.01144,543 shs$8.49 million03/14/2024$0.02$0.01-27.78%$0.02$0.01129,868 shs$6.13 million03/13/2024$0.01$0.02+80.00%$0.02$0.01144,543 shs$8.49 million03/12/2024$0.01$0.01-16.67%$0.03$0.01147,236 shs$4.72 million03/11/2024$0.02$0.01-42.86%$0.03$0.01147,236 shs$5.66 million03/08/2024$0.03$0.02-18.27%$0.03$0.02246,873 shs$10.03 million03/07/2024$0.03$0.03$0.03$0.02127,503 shs$12.27 million03/06/2024$0.02$0.03+30.00%$0.03$0.01127,503 shs$12.27 million03/05/2024$0.02$0.02$0.02$0.0154,407 shs$9.44 million03/04/2024$0.02$0.02$0.03$0.02199,315 shs$9.44 million03/01/2024$0.03$0.03$0.03$0.02112,678 shs$12.74 million02/29/2024$0.03$0.03+1.12%$0.03$0.02112,526 shs$12.74 million02/28/2024$0.03$0.03-4.64%$0.05$0.03195,283 shs$12.60 million02/27/2024$0.03$0.03$0.04$0.03117,697 shs$13.21 million02/26/2024$0.10$0.03-71.72%$0.04$0.03117,697 shs$13.21 million02/23/2024$0.04$0.04$0.04$0.03142,629 shs$17.70 million02/22/2024$0.03$0.04+20.97%$0.04$0.03142,629 shs$17.70 million02/21/2024$0.03$0.03+10.71%$0.03$0.0273,719 shs$14.63 million02/20/2024$0.03$0.03$0.05$0.02137,744 shs$13.21 million02/19/2024$0.03$0.03$0.05$0.02137,744 shs$13.21 million02/16/2024$0.05$0.05$0.05$0.02956,943 shs$22.65 million02/15/2024$0.03$0.05+92.00%$0.05$0.02956,943 shs$22.65 million02/14/2024$0.03$0.03$0.04$0.0222,989 shs$11.80 million02/13/2024$0.03$0.03$0.03$0.0172,381 shs$11.80 million02/12/2024$0.03$0.03$0.03$0.02156,951 shs$11.80 million02/09/2024$0.04$0.02-40.00%$0.10$0.014.71 million shs$10.62 million02/08/2024$0.04$0.04$0.04$0.02136,637 shs$17.70 million02/07/2024$0.02$0.04+87.50%$0.04$0.02136,637 shs$17.70 million02/06/2024$0.02$0.02-4.76%$0.05$0.011.12 million shs$9.44 million02/05/2024$0.02$0.02$0.05$0.02768,682 shs$9.91 million02/02/2024$0.05$0.05$0.05$0.03351,248 shs$25.48 million02/01/2024$0.04$0.05+27.06%$0.05$0.03351,248 shs$25.48 millionUrgent: Protect Your Investments from a Chinese Invasion (Ad)An alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.Click here to get my exclusive report NOW >>>01/31/2024$0.03$0.04+70.00%$0.06$0.00311,380 shs$20.06 million01/30/2024$0.03$0.03-10.71%$0.07$0.02312,436 shs$11.80 million01/29/2024$0.03$0.03$0.07$0.02601,531 shs$13.21 million01/26/2024$0.03$0.03$0.09$0.02510,709 shs$14.16 million01/25/2024$0.03$0.03+20.00%$0.04$0.01259,127 shs$14.16 million01/24/2024$0.03$0.03$0.04$0.01259,127 shs$11.80 million01/23/2024$0.03$0.03$0.06$0.02336,841 shs$11.80 million01/22/2024$0.04$0.03-41.18%$0.06$0.02336,491 shs$11.80 million01/19/2024$0.09$0.04-50.00%$0.09$0.03708,006 shs$20.06 million01/18/2024$0.10$0.09-16.67%$0.11$0.06384,617 shs$40.11 million01/17/2024$0.11$0.10-11.15%$0.12$0.101.09 million shs$48.13 million01/16/2024$0.11$0.11$0.12$0.073.18 million shs$54.17 million01/15/2024$0.11$0.11$0.12$0.073.18 million shs$54.17 million01/12/2024$0.12$0.11-3.19%$0.12$0.101.30 million shs$52.95 million01/11/2024$0.11$0.12+1.31%$0.12$0.11623,089 shs$54.69 million01/10/2024$0.11$0.11+4.00%$0.12$0.11583,514 shs$53.98 million01/09/2024$0.11$0.11$0.12$0.111.04 million shs$51.91 million01/08/2024$0.11$0.11$0.12$0.11866,559 shs$51.91 million01/05/2024$0.11$0.12+3.60%$0.12$0.102.00 million shs$54.27 million01/04/2024$0.12$0.11-8.94%$0.12$0.111.88 million shs$52.38 million01/03/2024$0.12$0.12-1.30%$0.14$0.111.78 million shs$57.52 million01/02/2024$0.12$0.12$0.14$0.116.17 million shs$58.28 million01/01/2024$0.12$0.12$0.14$0.116.17 million shs$58.28 million12/29/2023$0.13$0.12-5.00%$0.14$0.116.17 million shs$58.28 million12/28/2023$0.13$0.13+3.34%$0.16$0.116.17 million shs$61.34 million12/27/2023$0.15$0.13-14.88%$0.16$0.116.17 million shs$59.36 million Related Companies: NanoString Technologies Stock Chart Fresh Tracks Therapeutics Stock Chart Titan Pharmaceuticals Stock Chart NanoString Technologies Stock Chart Finch Therapeutics Group Stock Chart Kiromic BioPharma Stock Chart Avalon GloboCare Stock Chart Palisade Bio Stock Chart Creative Medical Technology Stock Chart Eiger BioPharmaceuticals Stock Chart Receive SRNE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sorrento Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SRNE) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sorrento Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.